Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

AT&T Posts 3.5% Revenue Gain in Q2


AT (NYSE:T), a major U.S. telecommunications company known for wireless and fiber broadband services, released its second-quarter 2025 results on July 23, 2025. The company reported revenue of $30.8 billion, surpassing Wall Street's expectation of $30.5 billion. Adjusted earnings per share (EPS) came in at $0.54, beating the analyst consensus of $0.53. The company also posted $4.4 billion in free cash flow, up from $4.0 billion a year earlier. Notably, its mobility and fiber segments delivered continued growth, helping offset softer business wireline results. Management described the quarter as solid, with execution on key strategic priorities and resumed share buybacks.

Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.

AT (NYSE:T) is a leading provider of wireless, broadband, and business connectivity in the United States and Latin America. It serves over 300 million people through its wireless network and passes millions of homes with its expanding fiber network. Its largest segments are Mobility, which includes wireless phone and data plans, and Consumer Wireline, mainly focused on fiber internet and broadband.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

0,13 €
0,00 %
Keine Kursänderung zu verzeichnen bei Allergy Therapeutics PLC seit dem Vortag.

Like: 0
T
Teilen

Kommentare